The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Local Anesthetics and the Inflammatory Response: A New Therapeutic Indication?
Open accessAbstract
LOCAL anesthetics (LA) are known for their ability to block Na+channels. However, they have significant effects in several settings other than local and regional anesthesia or antiarrhythmic treatment, the areas in which they are used traditionally. These effects result from LAs interacting with other cellular systems as well. Interestingly, some of these effects occur at concentrations much lower than those required for Na+channel blockade. For example, whereas the half-maximal inhibitory concentration (IC50) of lidocaine at the neuronal Na+channel is approximately 50–100 μm (depending on the specific channel subtype and study preparation), 1the compound inhibits signaling through m1 muscarinic receptors (expressed recombinantly in Xenopus laevis oocytes) with an IC50of 20 nm, that is, 1,000- to 5,000-fold lower. 2This sensitivity of other targets has two important consequences. First, we assume that LAs, at concentrations that result in significant Na+channel blockade, also affect a number of other systems. Second, relatively low LA concentrations (such as attained in blood during epidural anesthesia or analgesia or during intravenous LA infusion) that block neuronal Na+channels to a limited extent only still can have significant pharmacologic effects. We suggest that some of these “alternative actions” may be beneficial in the clinical setting, and others may be responsible for some adverse effects of LAs. Although Butterworth and Strichartz 3a decade ago urged investigation of such actions and their mechanisms, much remains to be discovered. To demonstrate the variety of LA effects, table 1provides an overview of various LA actions reported in the literature. This review focuses on an area in which alternative actions of LAs show much promise for clinical application: their effects on the inflammatory response and especially on inflammatory cells (mainly polymorphonuclear granulocytes [PMNs] but also macrophages and monocytes). PMNs do not express Na channels, 4and LA effects on these cells therefore are not caused by Na channel blockade. LA effects on these cells are not affected by Na channel blockers such as tetrodotoxin or veratridine. 5Overactive inflammatory responses that destroy rather than protect are critical in the development of a number of perioperative disease states, such as postoperative pain, 6–8adult respiratory distress syndrome (ARDS), 9–11systemic inflammatory response syndrome, and multiorgan failure. 12–15Perioperative modulation of such responses is therefore relevant to the practice of anesthesiology, and LAs may play significant roles in this regard.In general terms, inflammation can be described as a reaction of the host against injurious events such as tissue trauma or presence of pathogens. Release of vasoactive mediators from tissue mast cells (histamine, leukotrienes), as well as from platelets and plasma components (bradykinin), causes vasodilation and increased vascular permeability, leading to the classic inflammatory signs of redness (rubor ) and heat (calor ). The resulting edema causes swelling (tumor ), and interactions of inflammatory mediators with the sensory systems induce pain (dolor ). Significant local inflammation causes a systemic response, termed the acute phase reaction . This response is manifested by increases in acute phase proteins (C-reactive protein, complement factor C3, fibrinogen, and serum albumin), followed by activation of several systems of mediators (kinin system, complement system, lipid mediators, and cytokines). Cytokines, in particular, are important for regulation of the inflammatory response. The local release of cytokines (interleukin-1 [IL-1], IL-8, tumor necrosis factor [TNF]) coordinates the inflammatory response at the site of injury and induces neutrophil chemotaxis to the site of inflammation. Some cytokines (IL-1, IL-6, TNF) released from inflammatory sites mediate the systemic response. They induce fever and the acute phase reaction, mobilize neutrophils from the bone marrow, and promote lymphocyte proliferation.The inflammatory response induces cells (primarily PMNs and monocytes) to migrate into the affected area, in which they destroy pathogens, largely by phagocytosis. This process can be divided into several stages (fig. 1):The inflammatory response is essential for structural and functional repair of injured tissue. It is, however, a double-edged sword. Excessive generation of proinflammatory signals, as occurs in several disease states, can aggravate tissue damage because of products derived from inflammatory cells. This suggests that modulation of the inflammatory response (e.g. , by LAs) might prevent such tissue damage.This section describes some actions of LAs on inflammatory processes. We focus on three specific disease states relevant to anesthesiologists: inflammatory lung injury, increased microvascular permeability, and myocardial ischemia–reperfusion injury. In addition, we discuss briefly the use of LAs to tr
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,029
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.
Hille, B. (1977) · The Journal of general physiology · doi:10.1085/jgp.69.4.497 · Cited by 1,734
Di Rosa, M., Giroud, J. P., & Willoughby, D. A. (1971) · The Journal of Pathology · doi:10.1002/path.1711040103 · Cited by 1,402
Simpson, P. J., Todd, R. F., Fantone, J. C., Mickelson, J. K., Griffin, J. D., & Lucchesi, B. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113364 · Cited by 636
Groudine, S. B., Fisher, H. A. G., Kaufman, R. P., Patel, M. K., Wilkins, L. J., Mehta, S. A., & Lumb, P. D. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199802000-00003 · Cited by 316
Astrup, J., Sørensen, P. M., & Sørensen, H. R. (1981) · Anesthesiology · doi:10.1097/00000542-198109000-00013 · Cited by 186
Poste, G. H., Papahadjopoulos, D., & Gl, N. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4430 · Cited by 183
HAMM, R. J., TEMPLE, M. D., O'DELL, D. M., PIKE, B. R., & LYETH, B. G. (1996) · Journal of Neurotrauma · doi:10.1089/neu.1996.13.41 · Cited by 168
Local anesthetics, mepacrine, and propranolol are antagonists of calmodulin.
Volpi, M., Sha'afi, R. I., Epstein, P. M., Andrenyak, D. M., & Feinstein, M. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.795 · Cited by 160
Cited by
Hah, J. M., Bateman, B. T., Ratliff, J., Curtin, C., & Sun, E. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002458 · Cited by 728
Liu, S. S., Richman, J. M., Thirlby, R. C., & Wu, C. L. (2006) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.08.007 · Cited by 524
Pathophysiology and prevention of postoperative peritoneal adhesions
Arung, W. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i41.4545 · Cited by 499
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy
Iqbal, Z., Azmi, S., Yadav, R., Ferdousi, M., Kumar, M., Cuthbertson, D. J., Lim, J., Malik, R. A., & Alam, U. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.04.001 · Cited by 487
Liu, S. S., & Wu, C. L. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000255040.71600.41 · Cited by 435
Metadata
- Authors
- Hollmann, M. W., Durieux, M. E., & Fisher, D. M.
- Venue
- Anesthesiology
- Published
- 2000-09-01
- Volume
- 93
- Issue
- 3
- Pages
- 858-875
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2015591449
- Cited by
- 688
- References
- 34
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Local Anesthetics and the Inflammatory Response: A New Therapeutic Indication? https://app.cochat.ai/papers/10.1097/00000542-200009000-00038
- The paper
- Hollmann, M. W., Durieux, M. E., & Fisher, D. M. (2000). Local Anesthetics and the Inflammatory Response: A New Therapeutic Indication? Anesthesiology. https://doi.org/10.1097/00000542-200009000-00038
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.